SEC Form 4 · accession 0001185185-17-000854
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Cherin
Officer — CFO, Treasurer and PAO
Period of report
Apr 6, 2017
Accepted (ET)
Apr 7, 2017 · 8:23 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 3, 2017 | D | 950 | $0.52 | D | 373,000 | D | |
| Common Stock | Apr 3, 2017 | D | 3,000 | $0.52 | D | 370,000 | D | |
| Common Stock | Apr 3, 2017 | D | 2,000 | $0.60 | D | 368,000 | D | |
| Common Stock | Apr 3, 2017 | D | 1,000 | $0.61 | D | 367,000 | D | |
| Common Stock | Apr 3, 2017 | D | 2,000 | $0.54 | D | 365,000 | D | |
| Common Stock | Apr 4, 2017 | D | 2,000 | $0.75 | D | 363,000 | D |
Table II — derivative securities
No Table II lines on this filing.